GLOBAL NEWS
REUTERS
THE NEW YORK TIMES
YAHOO
US BUSINESS
CNBC
EQUITIES
THE WALL STREET JOURNAL
US MARKET
CNBC
MARKETWATCH
NASDAQ
YAHOO
US MARKET BLOGS
CNBC
REDDIT
ZERO HEDGE
US MUTUAL FUNDS BLOGS
INVESTORS BUSINESS DAILY
REDDIT
US NEWS
CNBC
MARKETWATCH
THE NEW YORK TIMES
YAHOO
 Save

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Five Below Inc (Symbol: FIVE) have crossed above the average analyst 12-month target price of $158.10, changing hands for $163.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Yeti Holdings Inc (Symbol: YETI) have crossed above the average analyst 12-month target price of $40.86, changing hands for $41.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Greenbrier Companies Inc (Symbol: GBX) have crossed above the average analyst 12-month target price of $43.67, changing hands for $44.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrad

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Merck & Co Inc (Symbol: MRK) have crossed above the average analyst 12-month target price of $103.30, changing hands for $105.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of TechnipFMC plc (Symbol: FTI) have crossed above the average analyst 12-month target price of $44.58, changing hands for $45.03/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40, changing hands for $80.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Lennar Corp (Symbol: LEN) have crossed above the average analyst 12-month target price of $127.57, changing hands for $131.08/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

Continue reading at Nasdaq

36m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Amentum Holdings Inc (Symbol: AMTM) have crossed above the average analyst 12-month target price of $28.18, changing hands for $30.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

Continue reading at Nasdaq

37m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of Medical Properties Trust Inc (Symbol: MPW) have crossed above the average analyst 12-month target price of $5.50, changing hands for $5.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra

Continue reading at Nasdaq

37m

US MARKET | Wed, 26 Nov 2025, 7:01AM ET In recent trading, shares of BankUnited Inc. (Symbol: BKU) have crossed above the average analyst 12-month target price of $42.11, changing hands for $43.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

Continue reading at Nasdaq

37m

US MARKET | Wed, 26 Nov 2025, 6:59AM ET In recent trading, shares of Viking Holdings Ltd (Symbol: VIK) have crossed above the average analyst 12-month target price of $64.31, changing hands for $67.87/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v

Continue reading at Nasdaq

39m

US MARKET | Wed, 26 Nov 2025, 6:59AM ET In recent trading, shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $141.64, changing hands for $146.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Continue reading at Nasdaq

39m

US MARKET | Wed, 26 Nov 2025, 6:59AM ET In recent trading, shares of Applied Materials, Inc. (Symbol: AMAT) have crossed above the average analyst 12-month target price of $238.68, changing hands for $242.46/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra

Continue reading at Nasdaq

39m

US MARKET | Wed, 26 Nov 2025, 6:57AM ET In recent trading, shares of S & T Bancorp Inc (Symbol: STBA) have crossed above the average analyst 12-month target price of $40.40, changing hands for $40.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Continue reading at Nasdaq

40m

US MARKET | Wed, 26 Nov 2025, 6:57AM ET In recent trading, shares of Solventum Corp (Symbol: SOLV) have crossed above the average analyst 12-month target price of $84.70, changing hands for $85.77/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

Continue reading at Nasdaq

40m

US MARKET | Wed, 26 Nov 2025, 6:57AM ET In recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $89.77, changing hands for $89.86/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down

Continue reading at Nasdaq

40m

US MARKET | Wed, 26 Nov 2025, 6:56AM ET In recent trading, shares of Atkore Inc (Symbol: ATKR) have crossed above the average analyst 12-month target price of $63.00, changing hands for $65.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation

Continue reading at Nasdaq

41m
more